Introduction
The enzyme dehydroquinate synthase (DHQS) catalyses the conversion of 3-deoxyd-arabino-heptulosonate-7-phosphate (DAHP) to dehydroquinate (DHQ), an intermediate in the biosynthesis of shikimate. The shikimate pathway is present in bacteria and microbial eukaryotes, but is absent in higher eukaryotes (Bentley, 1990) . Pathogenic bacteria mutants in this pathway are attenuated for virulence (Gunel-Ozcan et al., 1997) . Enzymes such as DHQS thus represent attractive targets for the development of novel antimicrobial drugs.
DHQS has been thoroughly characterized biochemically Moore et al., 1994; Widlanski et al., 1989) . More recently, X-ray crystal structures of Aspergillus nidulans DHQS (AnDHQS) have led to proposals for the mechanisms of catalysis (Carpenter et al., 1998) and domain closure (Nichols et al., 2003) .
We previously reported the identi®cation of nine different crystal forms of AnDHQS (forms A±I; Nichols et al., 2001) . Structure determination indicated that in the absence of the substrate analogue carbaphosphonate (CBP), DHQS was in an open form with a domain rotation of $12 (Brown et al., 2003; Nichols et al., 2003) compared with the closed ternary complex (Carpenter et al., 1998) . The mechanisms involved in the domain closure are complex: there are changes in three proximal elements that have substrate-contacting residues in the closed form (PE1±PE3) which propagate to ®ve distal elements having no direct contact with the substrate (DE1±DE5). These two sets of changes then act concertedly to cause the large-scale closure of the hinge, leading to the exclusion of bulk solvent and the formation of a tightly de®ned active-site 
Materials and methods
The cloning, expression and isolation of AnDHQS took place as described previously (Moore et al., 1994; van den Hombergh et al., 1992) . For crystallization, aliquots of puri®ed protein were concentrated and bufferexchanged into 10 mM Tris pH 7.4, 40 mM KCl using Vivascience Vivaspin 2 centrifugal concentrators with polyethersulfone membranes. Pooled concentrates were ®ltered through Amersham NAP 25 columns, reconcentrated to 30 mg ml À1 and pre-incubated at 277 K with 1 mM ZnCl 2 for 20 min; 50 mM DAHP was then added. Hampton Research sparse-matrix and grid screens were then set up (i.e. Crystal Screen I, Crystal Screen II, Crystal Screen Cryo, PEG/Ion, Natrix, MembFac, PEG/LiCl Grid, NaCl Grid, PEG 6000 Grid and A/S Grid Screens). All crystallizations were carried out at 277 K and set up as sittingdrop vapour-diffusion experiments utilizing microbridges.
short communications
Single frames of X-ray data were collected from the crystals that grew from the screens and the unit-cell parameters were characterized. A full X-ray diffraction data set was then collected for the new form J turnover-related crystal form. Data collection was carried out at the ESRF on beamline ID-14 EH4 (! = 0.933 A Ê ) at 100 K, with cryoprotection being provided by the displacement of aqueous media with per¯uoroether PFO-X125/03 (supplied by Lancaster). Indexing, integration and merging of data images were carried out with DENZO and SCALEPACK (Otwinowski & Minor, 1996) . Rotation-function and translation searches together with initial rigid-body Patterson correlation re®nement were carried out using CNS (Bru È nger et al., 1998). Molecular-replacement solutions were checked by displaying the transformed coordinates in O (Jones et al., 1991) . Rigidbody, positional and B-factor re®nement, simulated annealing and initial water picking were carried out in CNS. Manual rebuilding, including insertion of ions, ligands and extra water molecules, was carried out with O. The ®nal model was overlaid with previously released AnDHQS structures using Top3D (Collaborative Computational Project, Number 4, 1994); the results were compared visually in VMD (Humphrey et al., 1996) and ®nal ®gures prepared using Corel11.
Results and discussion
Characterization of crystals deriving from screens set up with AnDHQS and 50 mM DAHP revealed a new crystal form (form J) that was obtained under conditions that had not previously been seen to yield crystals with either NAD binary or NAD/CBP ternary setups. Data were therefore collected to determine the structure of the complex involved and compare it with other structures to assess any differences and see if it represented the crystallization of an intermediate stage in the domain-closure cycle. Although the crystals were extremely small (50 Â 20 Â 5 mm), they proved to be very well ordered, diffracting to 1.7 A Ê resolution. Autoindexing with DENZO indicated C-centred orthorhombic symmetry and analysis of systematic absences then allowed the ®nal assignment of space group as C222 1 . The C chain of PDB model 1nve (NAD binary complex) was used as an initial molecularreplacement search model and the ®rst cross-rotation peak gave a good translation search result with an E2E2 correlation of 0.383, yielding chain A of the new form. However, it was not so clear which of the other 22 peaks was the correct solution for the second moiety within the asymmetric unit. The monomeric initial solution was therefore subjected to rigid-body, positional and B-factor re®ne-ment, which lowered R free from 0.52 to 0.46, and was then used for a second cross-rotation search. The monomeric model was then copied to give chains A and B overlaid on one another and was used for a second translation search with chain A ®xed for translation but allowed to move in the ®nal rigid-body stage of the CNS translation-search script. The ®rst peak (excluding the origin) of the new crossrotation search was thus revealed as the correct peak for chain B, with the resultant dimer showing an E2E2 correlation of 0.734. Structural re®nement from this solution was then trivial, with only minor modi®cations being required after cyclic application of simulated annealing, positional/B-factor re®nement and automated water-picking/ deleting options. Representative electron density is shown in Figs. 1(a) and 1(b) and ®nal re®nement statistics are given in Table 1 .
With d min = 1.7 A Ê , the ®nal structure is of substantially higher resolution than the best extant open form of AnDHQS (PDB code 1nve; d min = 2.58 A Ê ) and the model contains in excess of 1300 waters, which is between two and four times greater than the number discernible previously. Second-order and even third-order hydration shells can be unambiguously discerned (Fig. 1b) , which may be because of the greater order of this crystal form but could also be the result of the use of the cryoprotectant per¯uoroether, which stabilizes hydration shells more effectively than, for example, glycerol.
Analysis of 2F o À F c and F o À F c maps shows no sign of electron density consistent with the presence of either substrate or Figure 1 Electron-density map at 1. 7 A Ê resolution for AnDHQS showing (a) the active-site region and (b) the presence of extended hydration shells. product (Fig. 1a) , although as expected the tightly bound cofactor NAD is present.
Comparison of the re®ned model with those previously reported for NAD binary and NAD/CBP ternary complexes (PDB models 1nve and 1nr5, respectively) also clearly shows the DHQS is`open form', with the Nand C-terminal domains counter-rotated by $12 compared with the`closed-form' model (Fig. 2a) . However, whilst the bulk state of the protein is clearly`open', the A-chain PE1 structural element is bent slightly towards the active site (Fig. 2a) (Figs. 2a and 2b ). This in turn affects crystal packing, with the semi-disordered DE4 and DE5 regions now making contacts with rigid regions of adjacent moieties in the crystal lattice rather than each other as observed with previous openform data.
One explanation of the observed conformation of AnDHQS in crystal form J is that as the enzyme relaxes back to the open form after the completion of its reaction cycle, it transiently passes through a conformation that can be trapped to yield this new crystal form. Uncertainty remains as to whether this is truly the ®nal-stage intermediate of domain opening, as the substantial changes in crystal packing may also induce structural changes in the surface contacts relative to their equivalent in vivo state. However, it is hoped that the availability of higher resolution open-form AnDHQS structures will facilitate the future design of inhibitors of this enzyme. In particular, the new structure may aid in the development of compounds which act by stabilizing the open form, an alternative design strategy compared with inhibitors occupying the substrate site. The general utility of enzyme turnover prior to crystallization is dif®cult to estimate but may be worth using, particularly if other methods fail to give goodquality crystals. We have successfully used this method to crystallize Varicella zoster virus thymidine kinase, although in this latter case both products remain bound to the active site following crystallization (Bird et al., 2003) .
